The company was established in 1989, completed the shareholding system reform in 2001, and was listed on the Shenzhen Stock Exchange in 2010. The company owns 8 modern pharmaceutical production workshops that comply with national GMP standards, including tablet, hard capsule, lyophilized powder injection, and power injection products.